Aclaris Therapeutics, Inc. (ACRS)

USD 1.44

(4.35%)

Revenue Summary of Aclaris Therapeutics, Inc.

  • Aclaris Therapeutics, Inc.'s latest annual revenue in 2023 was 31.24 Million USD , up 5.03% from previous year.
  • Aclaris Therapeutics, Inc.'s latest quarterly revenue in 2024 Q2 was 2.76 Million USD , up 15.35% from previous quarter.
  • Aclaris Therapeutics, Inc. reported a annual revenue of 29.75 Million USD in annual revenue 2022, up 340.05% from previous year.
  • Aclaris Therapeutics, Inc. reported a annual revenue of 6.76 Million USD in annual revenue 2021, up 4.3% from previous year.
  • Aclaris Therapeutics, Inc. reported a quarterly revenue of 2.76 Million USD for 2024 Q2, up 15.35% from previous quarter.
  • Aclaris Therapeutics, Inc. reported a quarterly revenue of 17.57 Million USD for 2023 Q4, up 89.29% from previous quarter.

Annual Revenue Chart of Aclaris Therapeutics, Inc. (2023 - 2013)

Historical Annual Revenue of Aclaris Therapeutics, Inc. (2023 - 2013)

Year Revenue Revenue Growth
2023 31.24 Million USD 5.03%
2022 29.75 Million USD 340.05%
2021 6.76 Million USD 4.3%
2020 6.48 Million USD 53.35%
2019 4.22 Million USD -58.11%
2018 10.09 Million USD 499.58%
2017 1.68 Million USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%

Peer Revenue Comparison of Aclaris Therapeutics, Inc.

Name Revenue Revenue Difference
Applied DNA Sciences, Inc. 13.36 Million USD -133.769%
Aspira Women's Health Inc. 9.15 Million USD -241.37%
Biodesix, Inc. 49.08 Million USD 36.34%
BioNexus Gene Lab Corp. 9.77 Million USD -219.82%
bioAffinity Technologies, Inc. 2.53 Million USD -1133.92%
bioAffinity Technologies, Inc. 2.53 Million USD -1133.92%
Bionano Genomics, Inc. 36.11 Million USD 13.476%
CareDx, Inc 280.32 Million USD 88.853%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 219.78 Million USD 85.782%
DarioHealth Corp. 20.35 Million USD -53.543%
Exact Sciences Corporation 2.49 Billion USD 98.75%
Fulgent Genetics, Inc. 289.21 Million USD 89.195%
Guardant Health, Inc. 563.94 Million USD 94.459%
ICON Public Limited Company 8.12 Billion USD 99.615%
IDEXX Laboratories, Inc. 3.66 Billion USD 99.146%
Illumina, Inc. 4.5 Billion USD 99.306%
Intelligent Bio Solutions Inc. 3.11 Million USD -904.216%
iSpecimen Inc. 9.92 Million USD -214.75%
Standard BioTools Inc. 106.34 Million USD 70.614%
MDxHealth SA 70.19 Million USD 55.481%
23andMe Holding Co. 219.63 Million USD 85.772%
Medpace Holdings, Inc. 1.88 Billion USD 98.343%
Myriad Genetics, Inc. 678.4 Million USD 95.394%
Mainz Biomed B.V. 895.47 Thousand USD -3389.641%
ENDRA Life Sciences Inc. - USD -Infinity%
NeoGenomics, Inc. 591.64 Million USD 94.718%
Neogen Corporation 924.22 Million USD 96.619%
Inotiv, Inc. 572.42 Million USD 94.541%
Natera, Inc. 1.08 Billion USD 97.113%
OPKO Health, Inc. 863.49 Million USD 96.381%
Psychemedics Corporation 22.09 Million USD -41.411%
Prenetics Global Limited 21.74 Million USD -43.722%
Prenetics Global Limited 21.74 Million USD -43.722%
Precipio, Inc. 15.19 Million USD -105.626%
Personalis, Inc. 73.48 Million USD 57.473%
RadNet, Inc. 1.61 Billion USD 98.067%
Sera Prognostics, Inc. 306 Thousand USD -10112.092%
Sotera Health Company 1.04 Billion USD 97.022%
Neuronetics, Inc. 71.34 Million USD 56.202%
Star Equity Holdings, Inc. 45.78 Million USD 31.748%
Star Equity Holdings, Inc. 45.78 Million USD 31.748%
Trinity Biotech plc 56.83 Million USD 45.015%
Twist Bioscience Corporation 312.97 Million USD 90.015%
Exagen Inc. 52.54 Million USD 40.532%